Abstract Substantially genetically stable continuous human cell lines derived from normal human mammary epithelial cells (HMEC) and processes for making and using the same. In a preferred embodiment, the cell lines are derived by treating normal human mammary epithelial tissue with a chemical carcinogen such as benzo[a]pyrene. The novel cell lines serve as useful substrates for elucidating the potential effects of a number of toxins, carcinogens and mutagens as well as of the addition of exogenous genetic material. The autogenic parent cells from which the cell lines are derived serve as convenient control samples for testing. The cell lines are not neoplastically transformed, although they have acquired several properties which distinguish them from their normal progenitors.
A biologically pure cell culture comprising a continuous human cell line derived from normal human mammary epithelial cells by means of treatment with a chemical carcinogen and selected from the group consisting of the cell lines having ATCC deposit numbers CRL8798 and CRL 8799.
Claim 2
Dependent Claim
44 words
A biologically pure cell culture comprising a continuous human cell line derived from normal human mammary epithelial cells by means of treatment with a chemical carcinogen and selected from the group consisting of the cell lines having ATCC deposit numbers CRL8798 and CRL 8799.
Claim 3
Dependent Claim
21 words
The composition of claim 1, wherein said cell line is a clone or subclone of ATCC deposit number CRL8798 or CRL8799.
Claim 4
Dependent Claim
14 words
The composition of claim 1, wherein said chemical carcinogen comprises a polycyclic aromatic hydrocarbon.
Claim 5
Dependent Claim
12 words
The composition of claim 3, wherein said polycyclic aromatic hydrocarbon is benzo[a]pyrene.